Drugs / PL3100
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01139190 | Jul → Dec 2010 | peptic ulcer disease | PLx Pharma | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PL3100 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01139190 ↗ |
| Route | Oral | “Oral administration” NCT01139190 ↗ |